Value in health regional issues · 2025
Cost Analysis of Epilepsy Healthcare in Adults: A Direct Cost Estimate From a Colombian Perspective.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alegría-Muñoz Maritza, Buitrago-Guzmán César A, Espinosa-Jovel Camilo, Ramírez-Molina Jorge L, Enciso-Zuluaga Mateo, Escobar Oscar A, Montaño-Padilla Gina, Espinosa-Almanza Carmelo J, Martínez Julieth, Navarro Cristian E
Аннотация
OBJECTIVES: To estimate the direct healthcare costs related to outpatient care and hospital stays for adults with epilepsy in the context of the Colombian healthcare system.
METHODS: A cost analysis was conducted from a base case, which included direct medical costs related to diagnosis, follow-up, pharmacological and surgical treatment, and in-hospital care for status epilepticus. A Delphi panel was carried out to identify and quantify cost-generating events. The monetary valuation was estimated using official databases and tariff manuals available in Colombia. The cost distribution was obtained using the bootstrapping method. Two one-way deterministic sensitivity analyses were performed.
RESULTS: The total annual cost of an adult patient with epilepsy without including hospital stays is US dollars $2416.31. If at least 1 intensive care unit stay (8-day average) is included to treat a patient with status epilepticus, the total annual cost increases to $61 567.72. The total cost of resective surgery is $14 894.44, and the vagus nerve stimulation implant costs $26 565.86.
CONCLUSIONS: Epilepsy in adults represents a significant economic burden for the Colombian healthcare system, comparable to that of other upper-middle-income countries. The majority of expenditure is attributed to intensive care unit stays, less financial resources would be required if patients achieve better control of the disease.
METHODS: A cost analysis was conducted from a base case, which included direct medical costs related to diagnosis, follow-up, pharmacological and surgical treatment, and in-hospital care for status epilepticus. A Delphi panel was carried out to identify and quantify cost-generating events. The monetary valuation was estimated using official databases and tariff manuals available in Colombia. The cost distribution was obtained using the bootstrapping method. Two one-way deterministic sensitivity analyses were performed.
RESULTS: The total annual cost of an adult patient with epilepsy without including hospital stays is US dollars $2416.31. If at least 1 intensive care unit stay (8-day average) is included to treat a patient with status epilepticus, the total annual cost increases to $61 567.72. The total cost of resective surgery is $14 894.44, and the vagus nerve stimulation implant costs $26 565.86.
CONCLUSIONS: Epilepsy in adults represents a significant economic burden for the Colombian healthcare system, comparable to that of other upper-middle-income countries. The majority of expenditure is attributed to intensive care unit stays, less financial resources would be required if patients achieve better control of the disease.